Terbinafine USP 250 mg as Terbinafine Hydrochloride Tablet.
Mycofree tablet is indicated for the treatment of : Onychomycosis of fingernails and toenails due to dermatophytes. Fungal infections of the skin (Tinea corporis, Tinea cruris, Tinea pedis). Hair and scalp infections (Tinea capitis). Yeast infections of the skin caused by the genus Candida (e.g. Candida albicans), where oral therapy is generally considered appropriate owing to the site, severity or extent of the infection.
Terbinafine USP 250 mg as Terbinafine Hydrochloride Tablet.
Mycofree tablet is indicated for the treatment of : Onychomycosis of fingernails and toenails due to dermatophytes. Fungal infections of the skin (Tinea corporis, Tinea cruris, Tinea pedis). Hair and scalp infections (Tinea capitis). Yeast infections of the skin caused by the genus Candida (e.g. Candida albicans), where oral therapy is generally considered appropriate owing to the site, severity or extent of the infection.
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.